This is consistent with the fact that phosphatidylinositol-3 kinase/mechanistic target of rapamycin (PI3K/mTOR) signaling mediates HER2 downstream signaling and is implicated in the pathogenesis of HER2-overexpressing breast cancers. The gene discussed is MTOR; the disease is breast carcinoma.